Early Prediction by 18F-FDG PET/CT for Progression-Free Survival and Overall Survival in Patients With Metastatic Colorectal Cancer Receiving Third-Line Cetuximab-Based Therapy

Title
Early Prediction by 18F-FDG PET/CT for Progression-Free Survival and Overall Survival in Patients With Metastatic Colorectal Cancer Receiving Third-Line Cetuximab-Based Therapy
Authors
Keywords
-
Journal
CLINICAL NUCLEAR MEDICINE
Volume 40, Issue 3, Pages 200-205
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2015-01-21
DOI
10.1097/rlu.0000000000000693

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now